Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA606040
Max Phase: Preclinical
Molecular Formula: C22H16N4OS
Molecular Weight: 384.46
Molecule Type: Small molecule
Associated Items:
ID: ALA606040
Max Phase: Preclinical
Molecular Formula: C22H16N4OS
Molecular Weight: 384.46
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccccc1/C=C/c1cn2c(-c3ccc4ccccc4n3)nnc2s1
Standard InChI: InChI=1S/C22H16N4OS/c1-27-20-9-5-3-7-16(20)10-12-17-14-26-21(24-25-22(26)28-17)19-13-11-15-6-2-4-8-18(15)23-19/h2-14H,1H3/b12-10+
Standard InChI Key: LEILYYNQIOHZQI-ZRDIBKRKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 384.46 | Molecular Weight (Monoisotopic): 384.1045 | AlogP: 5.19 | #Rotatable Bonds: 4 |
Polar Surface Area: 52.31 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 0.05 | CX LogP: 4.72 | CX LogD: 4.72 |
Aromatic Rings: 5 | Heavy Atoms: 28 | QED Weighted: 0.43 | Np Likeness Score: -1.15 |
1. Ko S, Lee MK, Shin D, Park H.. (2009) Structure-based virtual screening approach to the discovery of novel inhibitors of factor-inhibiting HIF-1: identification of new chelating groups for the active-site ferrous ion., 17 (22): [PMID:19822432] [10.1016/j.bmc.2009.09.034] |
Source(1):